The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand
- PMID: 34314786
- DOI: 10.1016/j.addr.2021.113897
The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand
Abstract
Physicochemical characterization of nanoparticles intended for immunology research is important as it helps explain the observed immunological effects. More importantly, it relates the physicochemical properties with the immunological properties to draw meaningful conclusions. There are many physicochemical parameters, with each having numerous analytical techniques and instrumentation to measure them. Thus, where to begin can be challenging even for the experienced scientist. This paper aims to provide guidance to the immunology scientist on how best to characterize their nanoparticles. A step-by-step guide for the physicochemical characterization of liposomal formulations, based on the FDA's guidance for industry for Liposome Drug Products, is provided. Eight critical quality attributes have been identified and for each, the methodology and the physicochemical questions one should consider are discussed. This chapter also addresses common physicochemical characterization mistakes and concludes with a perspective on the type of measurements needed to address current physicochemical characterization gaps and challenges.
Keywords: Batch-to-batch consistency; Critical quality attributes; Liposome drug products; Nanomedicine; Particle counting; Size/size distribution; Stability.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.Mol Pharm. 2019 Feb 4;16(2):756-767. doi: 10.1021/acs.molpharmaceut.8b01033. Epub 2019 Jan 16. Mol Pharm. 2019. PMID: 30604620 Free PMC article.
-
Characterization of Polymeric Nanoparticle Dispersions for Biomedical Applications: Size, Surface Charge and Stability.Pharm Nanotechnol. 2018;6(3):147-164. doi: 10.2174/2211738506666180706121515. Pharm Nanotechnol. 2018. PMID: 29984674 Review.
-
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.J Pharm Biomed Anal. 2021 Jan 5;192:113642. doi: 10.1016/j.jpba.2020.113642. Epub 2020 Sep 19. J Pharm Biomed Anal. 2021. PMID: 33011580 Review.
-
Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.Artif Cells Nanomed Biotechnol. 2017 Jun;45(4):788-799. doi: 10.1080/21691401.2017.1282496. Epub 2017 Feb 8. Artif Cells Nanomed Biotechnol. 2017. PMID: 28278586 Review.
-
Sizing up the Next Generation of Nanomedicines.Pharm Res. 2019 Dec 11;37(1):6. doi: 10.1007/s11095-019-2736-y. Pharm Res. 2019. PMID: 31828540 Free PMC article. Review.
Cited by
-
GL67 lipid-based liposomal formulation for efficient siRNA delivery into human lung cancer cells.Saudi Pharm J. 2023 Jul;31(7):1139-1148. doi: 10.1016/j.jsps.2023.05.017. Epub 2023 May 19. Saudi Pharm J. 2023. PMID: 37273265 Free PMC article.
-
Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin.Acta Pharmacol Sin. 2024 Mar;45(3):646-659. doi: 10.1038/s41401-023-01169-5. Epub 2023 Oct 16. Acta Pharmacol Sin. 2024. PMID: 37845342 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources